MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Delaware
This Membership Interest Purchase Agreement, dated as of April 30, 2020 (this “Agreement”), is entered into by and among (i) MLH NE Pennsylvania, LLC, a Delaware limited liability company (“Buyer”), (ii) Mission Pennsylvania II, LLC, a Pennsylvania limited liability company (the “Company”), (iii) Linchpin Investors, LLC, a Delaware limited liability company (the “RE Seller”) and 326 Bear Creek Commons LLC, a Delaware limited liability company (the “RE Company”), and (iv) 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (“Seller Parent”), Mission Mercury, LLC, a Delaware limited liability company (“Mission Mercury”) and PL Pennsylvania Dispensary, LLC, a Pennsylvania limited liability company (“PL PA” and together with Mission Mercury and the RE Seller, the “Sellers” and each, a “Seller”). The Seller Parent and the Sellers are sometimes referred to herein as the “Seller Parties.” The Buyer, the Company, the RE Company and the Seller Par
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arizona
This Separation Agreement and Release (this “Agreement”) is made as a compromise and release between 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia, Canada (the “Company”), and Joshua N. Rosen, an individual residing in the State of Arizona (“Employee”), in the complete, final, and binding settlement of all claims and potential claims, if any, with respect to their employment relationship.
AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Washington
This Amended and Restated Consulting Agreement, dated as of November 12, 2020 (this “Agreement”), is made and entered into by and among Ag-Grow Imports, LLC, a Washington limited liability company (the “Company”), 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia, Canada (“4Front”), and Maha Consulting LLC, a Puerto Rican limited liability company (“Consultant”).
TERMINATION AGREEMENTTermination Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Maryland
This Termination Agreement (the “Termination Agreement”), dated as of August 11, 2020 (the “Effective Date”), is by and among Premium Medicine of Maryland, LLC, a Maryland limited liability company (“Premium”), Silver Spring Consulting Group, LLC, a Delaware limited liability company (“SSCG”), Eric Steenstra, an individual resident in the State of Maryland (“Mr. Steenstra”), Dawn Steenstra, an individual resident in the State of Maryland (“Ms. Steenstra”), 4Front Advisors, LLC, an Arizona limited liability company (“4Front Advisors”), 4Front PM InvestCo, LLC, a Maryland limited liability company (“4Front InvestCo”), 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (“4Front”), and Bayside Partners, LLC, a Maryland limited liability company (“Bayside”). Each of Premium, SSCG, Mr. Steenstra, Ms. Steenstra, 4Front Advisors, 4Front InvestCo and Bayside is referred to herein as a “Party” and collectively as the “Parties”.
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arizona
This Separation Agreement and Release (this “Agreement”) is made as a compromise and release between 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia, Canada (the “Company”), and Nicolle Dorsey, an individual residing in the State of Arizona (“Employee”), in the complete, final, and binding settlement of all claims and potential claims, if any, with respect to their employment relationship.
SECOND ADDENDUM TO MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
THIS SECOND ADDENDUM (the “Second Addendum”) entered into on August 12, 2020, amends, modifies, supplements and clarifies the terms and conditions of that certain Membership Interest Purchase Agreement (the “Original Agreement”), dated as of January 22, 2020, by and among 4Front Holdings LLC, a Delaware limited liability company (“4F Holdings”), 4Front Arkansas, LLC, a Delaware limited liability company (“4F Arkansas”, and together with 4F Holdings, collectively, the “Seller”), and Denham Investments, LLC, an Arkansas limited liability company (“Buyer”).
ASSET PURCHASE AGREEMENTManagement Services Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Maryland
This Asset Purchase Agreement, dated as of April 30, 2020 (this “Agreement”), is entered into by and among (i) MLH Maryland Operations, LLC, a Delaware limited liability company (“Buyer”), and MLH Hampden Real Estate, LLC, a Delaware limited liability company and a wholly owned subsidiary of Buyer (“RE Buyer” and together with Buyer, the “Buyers”), (ii) Mission Maryland, LLC, a Maryland limited liability company (“Mission Maryland”), Adroit Consulting Group, LLC, a Delaware limited liability company (“Adroit”), Old Line State Consulting Group, LLC, a Delaware limited liability company (“Old Line” and together with Adroit, the “Sellers” and each, a “Seller”), and (iv) 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (“Seller Parent” and together with the Sellers and Mission Maryland, the “Seller Parties”). The Seller Parties and the Buyers are sometimes referred to herein as the “Parties,” and each, a “Party.”
MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arkansas
effective as of January 22, 2020 (the “Effective Date”), by and among, 4Front Holdings LLC, a Delaware limited liability company (“4F Holdings”), 4Front Arkansas, LLC, a Delaware limited liability company (“4F Arkansas”, and collectively with 4F Holdings the “Seller”), and Denham Investments, LLC, an Arkansas limited liability company (“Buyer”).
FIRST ADDENDUM TO MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
THIS FIRST ADDENDUM (the “Addendum”) entered into on March 31, 2020, amends, modifies, supplements and clarifies the terms and conditions of that certain Membership Interest Purchase Agreement (the “Agreement”), dated as of January 22, 2020, by and among 4Front Holdings, LLC, a Delaware limited liability company (“4F Holdings”), 4Front Arkansas, LLC, a Delaware limited liability company (“4F Arkansas”, and together with 4F Holdings, collectively, the “Seller”), and Denham Investments, LLC, an Arkansas limited liability company (“Buyer”). Terms capitalized but not otherwise defined herein shall have the meanings ascribed to them in the Agreement.
4FRONT VENTURES CORP. SEVERANCE GENERAL WAIVER AND RELEASE AGREEMENT Jerry DerevyannyGeneral Waiver and Release Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
4FRONT VENTURES CORP. SEVERANCE GENERAL WAIVER AND RELEASE AGREEMENT Brad KotanskyGeneral Waiver and Release Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
